Judith Swallow

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

M. Piccart, M. Filetti, R. Salazar, 2022, The Lancet Oncology.

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

M. Piccart, M. Filetti, R. Salazar, 2021, The Lancet Oncology.

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective

R. Salazar, J. Tabernero, D. Ferrante, 2021, Therapeutic advances in medical oncology.

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

M. Piccart, M. Filetti, F. Grosso, 2023, The Lancet Oncology.

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

M. Piccart, M. Filetti, F. Mazzoni, 2021, The Lancet. Oncology.

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

M. Filetti, R. Salazar, A. Maconi, 2022, European Journal of Cancer.